Inventor · disambiguated record
David Pleynet
Also filed as: PLEYNET DAVID · PLEYNET DAVID P · PLEYNET DAVID P M
14 granted patents·5 pending applications·213 citations·filing 2000–2024
93Inventor score
Files withORTHO MCNEIL PHARM INC3IMMUNOGEN INC2INCYTE SAN DIEGO2NEUROGENETIC PHARMACEUTICALS I2PFAHL MAGNUS2
Top patents by PatentIndex Score
19 records- 0191US7781442B2Compounds and uses thereof in modulating amyloid betaNEUROGENETIC PHARMACEUTICALS I·Filed 2007·Granted Aug 24, 2010·20 cites·21 claims
- 0290US7799808B2α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefromNEUROGENETIC PHARMACEUTICALS I·Filed 2007·Granted Sep 21, 2010·17 cites·26 claims
- 0390US6765013B2Thiazolidinedione derivatives for the treatment of diabetes and other diseasesINCYTE SAN DIEGO·Filed 2002·Granted Jul 20, 2004·37 cites·32 claims
- 0489US6515003B1Heterocyclic derivatives for the treatment of diabetes and other diseasesMAXIA PHARMACEUTICALS INC·Filed 2000·Granted Feb 4, 2003·42 cites·23 claims
- 0588US8017629B2Compounds and uses thereof in modulating amyloid βNEUROGENETIC PHARMACEUTICALS INC·Filed 2010·Granted Sep 13, 2011·16 cites·29 claims
- 0688US7244739B2Compounds and uses thereof in modulating amyloid betaTORREYPINES THERAPEUTICS INC·Filed 2004·Granted Jul 17, 2007·35 cites·48 claims
- 0786US11229639B2Camptothecin derivativesIMMUNOGEN INC·Filed 2020·Granted Jan 25, 2022·1 cites·7 claims
- 0886US8119680B2α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefromCHENG SOAN·Filed 2010·Granted Feb 21, 2012·13 cites·25 claims
- 0980US7226940B2Substituted heterocycles for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2005·Granted Jun 5, 2007·3 cites·20 claims
- 1078US7153875B2Heterocyclic derivatives for the treatment of cancer and other proliferative diseasesINCYTE SAN DIEGO·Filed 2002·Granted Dec 26, 2006·13 cites·9 claims
- 1177US7071218B2N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseasesORTHO MCNEIL PHARM INC·Filed 2002·Granted Jul 4, 2006·10 cites·45 claims
- 1274US6974826B2Imidazolidinedione derivatives for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2004·Granted Dec 13, 2005·5 cites·32 claims
- 1372US8263641B2Compounds that modulate intracellular calciumVELICELEBI GONUL·Filed 2008·Granted Sep 11, 2012·1 cites·8 claims
- 1468US2025195487A1Formulations of a csf-1r inhibitorDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1566US2022133711A1Camptothecin derivativesIMMUNOGEN INC·Filed 2021·Application pending·0 cites
- 1650US2006160796A1N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseasesPFAHL MAGNUS·Filed 2006·Application pending·0 cites
- 1749US8524765B2Compounds that modulate intracellular calciumVELICELEBI GONUL·Filed 2012·Granted Sep 3, 2013·0 cites·9 claims
- 1847US2005209286A1RXR activating moleculesPFAHL MAGNUS·Filed 2005·Application pending·0 cites
- 1938US2004097566A12-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancerFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Pleynet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →